T1	intervention 0 8	Exercise
T2	duration 192 199	8-month
T3	eligibility 269 309	women with newly diagnosed breast cancer
T4	location 346 355	Australia
T5	outcome-Measure 429 450	overall survival (OS)
T6	outcome-Measure 455 482	disease-free survival (DFS)
T7	No-of-participants 521 524	194
T8	No-of-participants 565 568	143
T9	control 655 665	usual care
T10	intervention-participants 818 821	207
T11	control-participants 862 865	130
T12	duration 913 922	8.3Â years
T13	outcome 945 951	deaths
T16	outcome 1096 1106	DFS events
T14	intervention-value 935 937	11
T19	intervention-value 939 943	5.3%
T15	control-value 988 990	15
T20	control-value 992 997	11.5%
T17	intervention-value 1153 1155	25
T21	intervention-value 1157 1162	12.1%
T18	control-value 1168 1170	23
T22	control-value 1172 1177	17.7%
